company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11589711.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11589711.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,450350.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,245425.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10852936.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10852936.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5145.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2250.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2895.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2895.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-264.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-264.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-264.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10856095.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13271735.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13271735.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,39019.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,371881.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1342015.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14202850.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14202850.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34507.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,825.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33682.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33682.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16863752.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2014.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16865766.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16865766.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2629234.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,344000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14975231.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14975231.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40519.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2136161.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1089493.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13888044.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13888044.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-321690.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-321690.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-321690.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-29672.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16391.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13281.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13281.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14223015.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,344000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12733692.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12733692.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35669.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,235542.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-120755.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12583236.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12583236.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102684.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-102684.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-102684.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45119999.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,40114.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45160113.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45160113.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32474193.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6648905.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6648905.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30108.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1590005.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2716393.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10925195.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10925195.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74322.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-74322.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-74322.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1234000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-141447.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1375448.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1375448.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12374965.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,344000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,260000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,260000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,145000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-661000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-234000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-234000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-108000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-108000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-108000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,372000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,372000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,372000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,71000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 08:31:31+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4583000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4583000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,146000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4613000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-930000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-754000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-754000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,18198000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18178000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18178000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4065000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-433000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-372000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4870000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4870000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12554000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,179000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4323000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1040734.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,381828.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3765.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2968891.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1542564.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-88816.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1631380.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33415.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-558.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33973.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33973.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-307.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,438.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,131.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,131.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1665222.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-388.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,301000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3583266.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,437172.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,217000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-112765.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6883109.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2758436.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-106184.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2864620.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29585.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,558.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2260000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2230973.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2230973.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,307.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-438.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,809000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,808869.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,808869.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,175222.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,388.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3359000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3359000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,703000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1070000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5179000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5179000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-118000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12517000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12635000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12635000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46694000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1030000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47724000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47724000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40268000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 08:31:31+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,60000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2363000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2363000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,706000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1923000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1688000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1954000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1954000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-253000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12517000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,12517000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-253000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-253000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-14000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-99000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-113000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-113000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1588000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-3000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6746000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6746000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1187000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1772000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5546000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4159000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4159000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-411000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-22117000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22528000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22528000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,458000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,458000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,458000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17911000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,77000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21005000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21005000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1282000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,559000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1692000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13797000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10741000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10741000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-338000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-338000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-338000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,138243000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-14659000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,123584000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,123584000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,133987000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4369000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4369000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1327000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1683000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,381000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6640000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1120000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1120000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-112000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4500000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4612000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4612000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3474000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:31:19+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6029000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3571000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3571000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1415000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1705000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,843000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6328000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1206000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1206000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-198000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-198000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-198000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,160000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,160000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,160000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1168000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2048000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3421000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4559000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4559000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2047000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1747000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3657000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1774000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10236000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10236000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-768000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-26000000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26768000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26768000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,714000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,714000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,714000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15818000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1218000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2876000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2876000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2111000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1696000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1382000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3363000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4702000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4702000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1105000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1105000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1105000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-113000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,287000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,174000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,174000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3771000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2157000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2587000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1346000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1346000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4609000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1725000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-84000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3373000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10969000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10969000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1369000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-84182000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-85551000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-85551000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2500000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,145000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2355000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2355000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-76937000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:32:30+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1643000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1125000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1125000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5956000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1757000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5945000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11446000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3337000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3337000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-719000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60312000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61031000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61031000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-294000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,256000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-38000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-38000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-57732000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2056000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,563000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2543000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2543000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5966000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1939000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2097000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11461000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1084000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1084000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1089000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1089000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1089000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1146000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1146000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1146000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1141000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3641000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1080000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1080000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5812000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1860000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10545000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5055000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12082000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12082000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1389000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1389000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1389000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,518000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,518000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,518000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11211000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2022000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3690000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1152000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1152000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6706000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1882000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,170000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3381000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6529000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6529000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2138000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50956000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53094000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53094000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,30000000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,25000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30025000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30025000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16540000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:31:22+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2681000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2681000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7101000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1908000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2468000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14157000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2304000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2304000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2304000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-153000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-153000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-153000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2456000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2097000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9878000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4720000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4720000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7099000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1933000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4455000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1123000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17084000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17084000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2480000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2480000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2480000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-5000000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,60000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4940000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4940000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9664000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,100000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2611000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9629000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9629000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7022000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1943000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5359000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11110000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15805000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15805000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3447000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-46668000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50115000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50115000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2737000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,50000000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,162000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47425000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47425000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13115000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1562000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5293000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2250000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2250000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8195000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2107000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,922000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9456000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22930000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22930000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2278000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2278000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2278000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1091000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1261000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,170000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,170000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20822000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:31:37+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,453000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2777000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2777000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8313000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2130000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1812000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6439000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8593000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8593000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1086000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5169000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6255000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6255000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,691000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,691000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,691000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3029000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2726000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2895000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5037000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5037000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8548000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2155000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8355000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15776000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8319000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8319000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1372000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-17067000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18439000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18439000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-937000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,206000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-731000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-731000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10851000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,584000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,995000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5430000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5430000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8686000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2073000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,78000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10965000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27232000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27232000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1007000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,600000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-407000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-407000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28482000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,536000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-27946000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-27946000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1121000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2522000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2507000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,449000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,449000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16103000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1873000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-666000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3468000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14291000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14291000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1775000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-18510000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20285000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20285000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-902000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2108000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1206000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1206000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4788000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,449000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:31:38+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6585000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6585000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9472000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1893000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10375000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-23581000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4744000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4744000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1634000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2324000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3958000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3958000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1580000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1580000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1580000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2366000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2488000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8723000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3895000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3895000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9473000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1913000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4570000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1942000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21793000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21793000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1523000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-409000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1932000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1932000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-903000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,133000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-770000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-770000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19091000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,690000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1170000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4835000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4835000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9564000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1345000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1641000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,370000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4803000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4803000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1703000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,329000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1374000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1374000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-119652000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,118886000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-766000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-766000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2663000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2465000.0
ANI Pharmaceuticals Inc,ANIP,5493000T6CXTND40YH31,0001023024,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,140000.0
